Clinical Study Shows Value of Nexstim’s Navigated Brain Stimulation (NBS) in Eloquent Cortex Surgery

HELSINKI--(BUSINESS WIRE)--Nexstim Oy, a medical device company developing non-invasive brain diagnostics and therapy technologies, announces presentation of the abstract “TMS as a part of multimodal management of safe glioma resection in the motor cortex” at the 60th Annual Meeting of the German Society of Neurosurgery.

MORE ON THIS TOPIC